Medpace Holdings Operating Cash Flow 2011-2026 | MEDP

Annual Operating Cash Flow Medpace Holdings

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
713 M	609 M	433 M	388 M	263 M	259 M	202 M	157 M	97.4 M	91.7 M	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
713 M	91.7 M	321 M

Quarterly Operating Cash Flow Medpace Holdings

2026-Q1	2025-Q4	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
152 M	-	-	-	126 M	-	-	-	153 M	-	-	-	80.1 M	-	251 M	-	46.3 M	-	192 M	-	57.3 M	-	153 M	93.4 M	49.1 M	-	145 M	80.6 M	34 M	-	117 M	64.6 M	23.3 M	-	68.7 M	29.7 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
251 M	23.3 M	101 M

Operating Cash Flow of other stocks in the Diagnostics research industry

Issuer	Operating Cash Flow	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	-21.7 M	-	-6.23 %	$ 30.6 M	Germany
Heska Corporation HSKA	-21.8 M	-	-	$ 1.31 B	USA
Fulgent Genetics FLGT	-102 M	$ 17.11	-1.55 %	$ 527 M	USA
ICON Public Limited Company ICLR	1.29 B	$ 116.78	0.18 %	$ 9.63 B	Irlanda
Agilent Technologies A	1.48 B	$ 114.96	0.15 %	$ 34.9 B	USA
Celcuity CELC	-153 M	$ 138.23	-3.02 %	$ 6.46 B	USA
Akumin AKU	65.4 M	-	-17.87 %	$ 25.9 M	Canada
Illumina ILMN	837 M	$ 144.41	-0.29 %	$ 23 B	USA
Co-Diagnostics CODX	-29.1 M	$ 5.07	36.66 %	$ 6.74 M	USA
Castle Biosciences CSTL	64.3 M	$ 20.15	-1.9 %	$ 584 M	USA
Aspira Women's Health AWH	-7.03 M	-	-6.19 %	$ 10.5 M	USA
Accelerate Diagnostics AXDX	-24.2 M	-	-61.36 %	$ 2.46 M	USA
Biocept BIOC	-13.3 M	-	-13.05 %	$ 7.29 M	USA
Guardant Health GH	-185 M	$ 118.95	0.8 %	$ 14.9 B	USA
CareDx, Inc CDNA	42 M	$ 21.63	0.28 %	$ 1.15 B	USA
Chembio Diagnostics CEMI	-12.7 M	-	0.22 %	$ 16.8 M	USA
Check-Cap Ltd. CHEK	-46 K	-	-	$ 9.42 M	Israel
HTG Molecular Diagnostics HTGM	-18.4 M	-	-20.0 %	$ 1.06 M	USA
Interpace Biosciences IDXG	5.83 M	$ 1.82	1.11 %	$ 8.05 M	USA
Lantheus Holdings LNTH	390 M	$ 103.0	9.03 %	$ 6.95 B	USA
Global Cord Blood Corporation CO	614 M	-	-	$ 399 M	China
Mettler-Toledo International MTD	956 M	$ 1 103.09	1.16 %	$ 22.7 B	Schweiz
Genetic Technologies Limited GENE	-9.68 M	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	-524 M	-	0.12 %	$ 80.1 M	China
NeoGenomics NEO	5.23 M	$ 9.23	1.32 %	$ 1.18 B	USA
National Research Corporation NRC	26.4 M	$ 19.08	0.21 %	$ 427 M	USA
DermTech DMTK	-77 M	-	-11.32 %	$ 2.94 M	USA
Natera NTRA	-432 M	$ 203.19	-0.25 %	$ 20 B	USA
Charles River Laboratories International CRL	738 M	$ 160.3	0.91 %	$ 7.95 B	USA
Enzo Biochem ENZ	-26.3 M	-	-8.98 %	$ 14.8 K	USA
Exact Sciences Corporation EXAS	491 M	-	-	$ 19.8 B	USA
Myriad Genetics MYGN	1.8 M	$ 3.82	-2.3 %	$ 354 M	USA
Personalis PSNL	-74.9 M	$ 8.47	2.67 %	$ 756 M	USA
Senseonics Holdings SENS	-59.1 M	$ 6.34	2.92 %	$ 265 M	USA
QIAGEN N.V. QGEN	654 M	-	-	$ 10.6 B	Niderland
Soleno Therapeutics SLNO	46.8 M	-	-	$ 2.69 B	USA
Biomerica BMRA	-3.84 M	$ 2.49	2.05 %	$ 5.72 M	USA
Twist Bioscience Corporation TWST	-47.6 M	$ 60.57	2.95 %	$ 3.62 B	USA
Laboratory Corporation of America Holdings LH	1.64 B	$ 259.93	1.63 %	$ 21.6 B	USA
Thermo Fisher Scientific TMO	7.82 B	$ 448.28	-0.24 %	$ 169 B	USA
Trinity Biotech plc TRIB	-4.19 M	$ 0.6	-3.7 %	$ 216 M	Irlanda
Motus GI Holdings MOTS	-11.2 M	-	-34.28 %	$ 263 K	Israel
Neogen Corporation NEOG	58.2 M	$ 8.9	0.45 %	$ 1.93 B	USA
Waters Corporation WAT	653 M	$ 342.37	0.4 %	$ 20.4 B	USA
Quest Diagnostics Incorporated DGX	1.89 B	$ 195.21	0.72 %	$ 21.7 B	USA